Bruce & Co’s Pfizer PFE Stock Holding History

Bruce & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.63M	Hold	271,900	–	–	2.18%	18
2025 Q4	$6.77M	Hold	271,900	–	–	2.1%	17
2025 Q3	$6.93M	Hold	271,900	–	–	2.15%	16
2025 Q2	$6.59M	Hold	271,900	–	–	2.14%	15
2025 Q1	$6.89M	Hold	271,900	–	–	2.21%	15
2024 Q4	$7.21M	Sell	271,900 -4,500	-2%	-$122K	2.32%	15
2024 Q3	$8M	Hold	276,400	–	–	2.33%	13
2024 Q2	$7.73M	Buy	276,400 +7,900	+3%	+$217K	2.54%	13
2024 Q1	$7.45M	Hold	268,500	–	–	2.47%	12
2023 Q4	$7.73M	Sell	268,500 -251,000	-48%	-$7.59M	2.7%	12
2023 Q3	$17.2M	Sell	519,500 -19,126	-4%	-$676K	5.87%	9
2023 Q2	$19.8M	Hold	538,626	–	–	5.54%	8
2023 Q1	$22M	Sell	538,626 -4,074	-0.8%	-$176K	5.99%	8
2022 Q4	$27.8M	Hold	542,700	–	–	7.17%	5
2022 Q3	$23.7M	Hold	542,700	–	–	6.53%	9
2022 Q2	$28.5M	Hold	542,700	–	–	6.69%	9
2022 Q1	$28.1M	Sell	542,700 -1,000	-0.2%	-$51.9K	5.74%	9
2021 Q4	$32.1M	Sell	543,700 -1,000	-0.2%	-$49.5K	6.42%	6
2021 Q3	$23.4M	Sell	544,700 -21,932	-4%	-$972K	4.98%	11
2021 Q2	$22.2M	Sell	566,632 -1,000	-0.2%	-$38.9K	4.24%	12
2021 Q1	$20.6M	Buy	567,632 +49,800	+10%	+$1.77M	3.85%	12
2020 Q4	$19.1M	Sell	517,832 -27,963	-5%	-$1.03M	3.67%	12
2020 Q3	$19M	Hold	545,795	–	–	3.94%	12
2020 Q2	$16.9M	Hold	545,795	–	–	3.68%	12
2020 Q1	$16.9M	Hold	545,795	–	–	3.89%	12
2019 Q4	$20.3M	Hold	545,795	–	–	3.96%	12
2019 Q3	$18.6M	Buy	545,795 +9,486	+2%	+$345K	3.86%	12
2019 Q2	$22M	Sell	536,309 -49,011	-8%	-$1.95M	4.7%	9
2019 Q1	$23.6M	Hold	585,320	–	–	4.61%	9
2018 Q4	$24.2M	Hold	585,320	–	–	5.16%	8
2018 Q3	$24.5M	Hold	585,320	–	–	4.74%	8
2018 Q2	$20.1M	Hold	585,320	–	–	4.01%	10
2018 Q1	$19.7M	Buy	585,320 +105,400	+22%	+$3.62M	4.12%	9
2017 Q4	$16.5M	Hold	479,920	–	–	3.57%	9
2017 Q3	$16.3M	Hold	479,920	–	–	3.63%	11
2017 Q2	$15.3M	Hold	479,920	–	–	3.49%	11
2017 Q1	$15.6M	Hold	479,920	–	–	3.73%	9
2016 Q4	$14.8M	Hold	479,920	–	–	3.86%	8
2016 Q3	$15M	Hold	479,920	–	–	4.06%	8
2016 Q2	$16M	Hold	479,920	–	–	4.1%	8
2016 Q1	$13.5M	Hold	479,920	–	–	3.76%	9
2015 Q4	$14.7M	Hold	479,920	–	–	3.99%	8
2015 Q3	$14.3M	Hold	479,920	–	–	3.68%	6
2015 Q2	$15.3M	Hold	479,920	–	–	3.95%	6
2015 Q1	$15.9M	Hold	479,920	–	–	4.04%	5
2014 Q4	$14.2M	Buy	479,920 +3,512	+0.7%	+$101K	3.92%	9
2014 Q3	$13.1M	Hold	476,408	–	–	3.66%	9
2014 Q2	$13.4M	Hold	476,408	–	–	3.09%	8
2014 Q1	$14.5M	Hold	476,408	–	–	3.9%	8
2013 Q4	$13.8M	Buy	476,408 +21,080	+5%	+$614K	3.94%	6
2013 Q3	$12.1M	Hold	455,328	–	–	3.95%	7
2013 Q2	$12.1M	Buy	+455,328	New	+$12.6M	4.05%	7

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bruce & Co's PFE Position: Q1 2026 in Review

Bruce & Co held its Pfizer (PFE) position steady in Q1 2026 at 271,900 shares worth $7.63M. The position accounts for 2.18% of the portfolio, ranked #18.

Bruce & Co first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.1M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Bruce & Co held 271,900 shares of Pfizer worth $7.63M as of Q1 2026.
Bruce & Co left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 2.18% of Bruce & Co's portfolio in Q1 2026, its #18 holding.
Bruce & Co first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Bruce & Co's Pfizer position peaked at $32.1M in Q4 2021.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bruce & Co's 13F filing for Q1 2026, filed 14 May 2026.